Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Transplant Cell Ther. 2022 Mar 11;28(6):294–302. doi: 10.1016/j.jtct.2022.03.006
Suggested future research directions for ICANS related studies:
  • Utilize consensus grading ICANS scales across studies

  • Develop and validate risk prediction models for the identification of those most likely to develop high-grade ICANS related complications

  • Conduct longitudinal studies to assess the long-term outcomes following CAR-T cell therapy with a focus on late-term neurotoxic complications

  • Evaluate the effects of CAR-T cell therapy in real-world populations and more vulnerable populations such as older adults

  • Develop interventions to support, manage or prevent the onset of ICANS